UBS Group AG - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 59 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q4 2020$7,0000.0%7,0000.0%0.00%
Q3 2020$7,0000.0%7,0000.0%0.00%
Q2 2020$7,000
+40.0%
7,000
+40.0%
0.00%
Q1 2020$5,0000.0%5,0000.0%0.00%
Q4 2019$5,0000.0%5,0000.0%0.00%
Q3 2019$5,0000.0%5,0000.0%0.00%
Q2 2019$5,0000.0%5,0000.0%0.00%
Q1 2019$5,000
-28.6%
5,000
-37.5%
0.00%
Q4 2018$7,000
-46.2%
8,000
-42.9%
0.00%
Q3 2018$13,0000.0%14,0000.0%0.00%
Q2 2018$13,000
+8.3%
14,0000.0%0.00%
Q1 2018$12,000
-33.3%
14,000
-30.0%
0.00%
Q4 2017$18,000
+28.6%
20,000
+33.3%
0.00%
Q3 2017$14,000
-82.5%
15,000
-80.0%
0.00%
Q2 2017$80,000
-1.2%
75,0000.0%0.00%
Q1 2017$81,000
+2.5%
75,000
+4.2%
0.00%
Q4 2016$79,0000.0%72,000
+9.1%
0.00%
Q3 2016$79,000
-6.0%
66,000
-1.5%
0.00%
Q2 2016$84,000
-3.4%
67,0000.0%0.00%
Q1 2016$87,000
-17.1%
67,0000.0%0.00%
Q4 2015$105,000
+15.4%
67,0000.0%0.00%
Q3 2015$91,000
-3.2%
67,0000.0%0.00%
Q2 2015$94,000
-5.1%
67,0000.0%0.00%
Q1 2015$99,000
+7.6%
67,0000.0%0.00%
Q4 2014$92,00067,0000.00%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q2 2019
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 70,783,000$69,363,0006.27%
INCOME RESEARCH & MANAGEMENT 14,978,000$14,536,0005.17%
PIPER SANDLER & CO. 5,000,000$4,852,0003.63%
Western Asset Management Company, LLC 42,946,000$42,102,0003.46%
PenderFund Capital Management Ltd. 4,000,000$5,225,0001.45%
Bracebridge Capital, LLC 5,500,000$5,335,0000.85%
WESTWOOD HOLDINGS GROUP INC 43,185,000$42,490,0000.54%
CORBYN INVESTMENT MANAGEMENT INC/MD 1,025,000$995,0000.52%
LMR Partners LLP 22,235,000$21,742,0000.45%
JUPITER ASSET MANAGEMENT LTD 35,000,000$34,357,0000.36%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders